New preprint: predicting rifampicin resistance Philip Fowler, 16th August 202416th August 2024 In this preprint we train a series of machine learning models on protein mutations found in rpoB — this is the gene in the M. tuberculosis RNA polymerase complex where mutations can introduce resistance to rifampicin, an important first-line drug in the treatment of tuberculosis. Unlike pyrazinamide, which we have previously published and binds to pncA, the RNA polymerase is an essential gene and therefore resistance-conferring mutations tend to be subtle and, in this case, mostly close to the rifampicin binding site. We find that all the models achieve similar levels of prediction performance and that the most predictive feature is, perhaps unsurprisingly, the distance from the amino acid being mutated to the centre of mass of rifampicin. All the data and code required to create our Test+Train datasets, train the models and produce nearly all the figures in the preprint is available on GitHub. Share this:TwitterBlueskyEmailLinkedInMastodon Related antimicrobial resistance computing publication research tuberculosis
antimicrobial resistance New paper: detecting compensatory mutations in the RNAP of M. tuberculosis 5th February 20245th February 2024 In this paper, by examining testing the association between mutations known to be associate with… Share this:TwitterBlueskyEmailLinkedInMastodon Read More
antimicrobial resistance I’ve moved… 14th March 20165th August 2018 Today is my first day as a Senior Researcher in Modernising Medical Microbiology in the… Share this:TwitterBlueskyEmailLinkedInMastodon Read More
Desirable features for any antibiotic resistance catalogue 31st October 202331st October 2023 In the past few years a growing number of catalogues containing mutations associated with resistance… Share this:TwitterBlueskyEmailLinkedInMastodon Read More